The global market for Biologics Regulatory Affairs Outsourcing was valued at US$ 2023 million in the year 2024 and is projected to reach a revised size of US$ 3902 million by 2031, growing at a CAGR of 9.1% during the forecast period.

Biologics Regulatory Affairs Outsourcing Market

Biologics regulatory affairs outsourcing is a commercial service in which biologics companies entrust regulatory affairs-related work to external professional organizations. Biologics include complex pharmaceutical products such as vaccines, blood products, recombinant proteins, monoclonal antibodies, etc., and the research and development, production, sales and use of these products are subject to strict regulatory supervision. Regulatory affairs outsourcing involves ensuring that these biologics comply with relevant domestic and international regulatory requirements at all stages, including but not limited to clinical trial applications, drug registrations, license applications, quality standard formulation and maintenance, regulatory compliance supervision, etc.

North American market for Biologics Regulatory Affairs Outsourcing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Biologics Regulatory Affairs Outsourcing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Biologics Regulatory Affairs Outsourcing in Monoclonal Antibodies (mAbs) is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Biologics Regulatory Affairs Outsourcing include Lonza AG, Wuxi AppTec Inc., Thermo Fisher Scientific Inc., Eurofins Scientific SE, Freyr solutions, Catalent Inc., Piramal Group, AGC Biologics, ICON Plc., Charles River Laboratories International, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Biologics Regulatory Affairs Outsourcing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics Regulatory Affairs Outsourcing.

The Biologics Regulatory Affairs Outsourcing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biologics Regulatory Affairs Outsourcing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biologics Regulatory Affairs Outsourcing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Biologics Regulatory Affairs Outsourcing Market Report

Report Metric	Details
Report Name	Biologics Regulatory Affairs Outsourcing Market
Accounted market size in year	US$ 2023 million
Forecasted market size in 2031	US$ 3902 million
CAGR	9.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Regulatory Consulting Legal Representation Regulatory Writing & Publishing Product Registration Regulatory Submissions Regulatory Operations Others
Segment by Application	Monoclonal Antibodies (mAbs) Recombinant Proteins Vaccines Cell & Gene Therapies Biosimilars Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Lonza AG, Wuxi AppTec Inc., Thermo Fisher Scientific Inc., Eurofins Scientific SE, Freyr solutions, Catalent Inc., Piramal Group, AGC Biologics, ICON Plc., Charles River Laboratories International, Inc., Labcorp, Parexel International, Medpace Holdings, Inc., IQVIA, Syneos Health, SGS SA (SGS)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics Regulatory Affairs Outsourcing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Biologics Regulatory Affairs Outsourcing Market growing?

Ans: The Biologics Regulatory Affairs Outsourcing Market witnessing a CAGR of 9.1% during the forecast period 2025-2031.

What is the Biologics Regulatory Affairs Outsourcing Market size in 2031?

Ans: The Biologics Regulatory Affairs Outsourcing Market size in 2031 will be US$ 3902 million.

Who are the main players in the Biologics Regulatory Affairs Outsourcing Market report?

Ans: The main players in the Biologics Regulatory Affairs Outsourcing Market are Lonza AG, Wuxi AppTec Inc., Thermo Fisher Scientific Inc., Eurofins Scientific SE, Freyr solutions, Catalent Inc., Piramal Group, AGC Biologics, ICON Plc., Charles River Laboratories International, Inc., Labcorp, Parexel International, Medpace Holdings, Inc., IQVIA, Syneos Health, SGS SA (SGS)

What are the Application segmentation covered in the Biologics Regulatory Affairs Outsourcing Market report?

Ans: The Applications covered in the Biologics Regulatory Affairs Outsourcing Market report are Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, Cell & Gene Therapies, Biosimilars, Others

What are the Type segmentation covered in the Biologics Regulatory Affairs Outsourcing Market report?

Ans: The Types covered in the Biologics Regulatory Affairs Outsourcing Market report are Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product Registration, Regulatory Submissions, Regulatory Operations, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biologics Regulatory Affairs Outsourcing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Regulatory Consulting

1.2.3 Legal Representation

1.2.4 Regulatory Writing & Publishing

1.2.5 Product Registration

1.2.6 Regulatory Submissions

1.2.7 Regulatory Operations

1.2.8 Others

1.3 Market by Application

1.3.1 Global Biologics Regulatory Affairs Outsourcing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Monoclonal Antibodies (mAbs)

1.3.3 Recombinant Proteins

1.3.4 Vaccines

1.3.5 Cell & Gene Therapies

1.3.6 Biosimilars

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biologics Regulatory Affairs Outsourcing Market Perspective (2020-2031)

2.2 Global Biologics Regulatory Affairs Outsourcing Growth Trends by Region

2.2.1 Global Biologics Regulatory Affairs Outsourcing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Biologics Regulatory Affairs Outsourcing Historic Market Size by Region (2020-2025)

2.2.3 Biologics Regulatory Affairs Outsourcing Forecasted Market Size by Region (2026-2031)

2.3 Biologics Regulatory Affairs Outsourcing Market Dynamics

2.3.1 Biologics Regulatory Affairs Outsourcing Industry Trends

2.3.2 Biologics Regulatory Affairs Outsourcing Market Drivers

2.3.3 Biologics Regulatory Affairs Outsourcing Market Challenges

2.3.4 Biologics Regulatory Affairs Outsourcing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biologics Regulatory Affairs Outsourcing Players by Revenue

3.1.1 Global Top Biologics Regulatory Affairs Outsourcing Players by Revenue (2020-2025)

3.1.2 Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Players (2020-2025)

3.2 Global Top Biologics Regulatory Affairs Outsourcing Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Biologics Regulatory Affairs Outsourcing Revenue

3.4 Global Biologics Regulatory Affairs Outsourcing Market Concentration Ratio

3.4.1 Global Biologics Regulatory Affairs Outsourcing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biologics Regulatory Affairs Outsourcing Revenue in 2024

3.5 Global Key Players of Biologics Regulatory Affairs Outsourcing Head office and Area Served

3.6 Global Key Players of Biologics Regulatory Affairs Outsourcing, Product and Application

3.7 Global Key Players of Biologics Regulatory Affairs Outsourcing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Biologics Regulatory Affairs Outsourcing Breakdown Data by Type

4.1 Global Biologics Regulatory Affairs Outsourcing Historic Market Size by Type (2020-2025)

4.2 Global Biologics Regulatory Affairs Outsourcing Forecasted Market Size by Type (2026-2031)

5 Biologics Regulatory Affairs Outsourcing Breakdown Data by Application

5.1 Global Biologics Regulatory Affairs Outsourcing Historic Market Size by Application (2020-2025)

5.2 Global Biologics Regulatory Affairs Outsourcing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Biologics Regulatory Affairs Outsourcing Market Size (2020-2031)

6.2 North America Biologics Regulatory Affairs Outsourcing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Biologics Regulatory Affairs Outsourcing Market Size by Country (2020-2025)

6.4 North America Biologics Regulatory Affairs Outsourcing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biologics Regulatory Affairs Outsourcing Market Size (2020-2031)

7.2 Europe Biologics Regulatory Affairs Outsourcing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Biologics Regulatory Affairs Outsourcing Market Size by Country (2020-2025)

7.4 Europe Biologics Regulatory Affairs Outsourcing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size (2020-2031)

8.2 Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size by Region (2020-2025)

8.4 Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Biologics Regulatory Affairs Outsourcing Market Size (2020-2031)

9.2 Latin America Biologics Regulatory Affairs Outsourcing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Biologics Regulatory Affairs Outsourcing Market Size by Country (2020-2025)

9.4 Latin America Biologics Regulatory Affairs Outsourcing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size (2020-2031)

10.2 Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Country (2020-2025)

10.4 Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Lonza AG

11.1.1 Lonza AG Company Details

11.1.2 Lonza AG Business Overview

11.1.3 Lonza AG Biologics Regulatory Affairs Outsourcing Introduction

11.1.4 Lonza AG Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

11.1.5 Lonza AG Recent Development

11.2 Wuxi AppTec Inc.

11.2.1 Wuxi AppTec Inc. Company Details

11.2.2 Wuxi AppTec Inc. Business Overview

11.2.3 Wuxi AppTec Inc. Biologics Regulatory Affairs Outsourcing Introduction

11.2.4 Wuxi AppTec Inc. Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

11.2.5 Wuxi AppTec Inc. Recent Development

11.3 Thermo Fisher Scientific Inc.

11.3.1 Thermo Fisher Scientific Inc. Company Details

11.3.2 Thermo Fisher Scientific Inc. Business Overview

11.3.3 Thermo Fisher Scientific Inc. Biologics Regulatory Affairs Outsourcing Introduction

11.3.4 Thermo Fisher Scientific Inc. Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

11.3.5 Thermo Fisher Scientific Inc. Recent Development

11.4 Eurofins Scientific SE

11.4.1 Eurofins Scientific SE Company Details

11.4.2 Eurofins Scientific SE Business Overview

11.4.3 Eurofins Scientific SE Biologics Regulatory Affairs Outsourcing Introduction

11.4.4 Eurofins Scientific SE Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

11.4.5 Eurofins Scientific SE Recent Development

11.5 Freyr solutions

11.5.1 Freyr solutions Company Details

11.5.2 Freyr solutions Business Overview

11.5.3 Freyr solutions Biologics Regulatory Affairs Outsourcing Introduction

11.5.4 Freyr solutions Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

11.5.5 Freyr solutions Recent Development

11.6 Catalent Inc.

11.6.1 Catalent Inc. Company Details

11.6.2 Catalent Inc. Business Overview

11.6.3 Catalent Inc. Biologics Regulatory Affairs Outsourcing Introduction

11.6.4 Catalent Inc. Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

11.6.5 Catalent Inc. Recent Development

11.7 Piramal Group

11.7.1 Piramal Group Company Details

11.7.2 Piramal Group Business Overview

11.7.3 Piramal Group Biologics Regulatory Affairs Outsourcing Introduction

11.7.4 Piramal Group Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

11.7.5 Piramal Group Recent Development

11.8 AGC Biologics

11.8.1 AGC Biologics Company Details

11.8.2 AGC Biologics Business Overview

11.8.3 AGC Biologics Biologics Regulatory Affairs Outsourcing Introduction

11.8.4 AGC Biologics Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

11.8.5 AGC Biologics Recent Development

11.9 ICON Plc.

11.9.1 ICON Plc. Company Details

11.9.2 ICON Plc. Business Overview

11.9.3 ICON Plc. Biologics Regulatory Affairs Outsourcing Introduction

11.9.4 ICON Plc. Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

11.9.5 ICON Plc. Recent Development

11.10 Charles River Laboratories International, Inc.

11.10.1 Charles River Laboratories International, Inc. Company Details

11.10.2 Charles River Laboratories International, Inc. Business Overview

11.10.3 Charles River Laboratories International, Inc. Biologics Regulatory Affairs Outsourcing Introduction

11.10.4 Charles River Laboratories International, Inc. Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

11.10.5 Charles River Laboratories International, Inc. Recent Development

11.11 Labcorp

11.11.1 Labcorp Company Details

11.11.2 Labcorp Business Overview

11.11.3 Labcorp Biologics Regulatory Affairs Outsourcing Introduction

11.11.4 Labcorp Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

11.11.5 Labcorp Recent Development

11.12 Parexel International

11.12.1 Parexel International Company Details

11.12.2 Parexel International Business Overview

11.12.3 Parexel International Biologics Regulatory Affairs Outsourcing Introduction

11.12.4 Parexel International Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

11.12.5 Parexel International Recent Development

11.13 Medpace Holdings, Inc.

11.13.1 Medpace Holdings, Inc. Company Details

11.13.2 Medpace Holdings, Inc. Business Overview

11.13.3 Medpace Holdings, Inc. Biologics Regulatory Affairs Outsourcing Introduction

11.13.4 Medpace Holdings, Inc. Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

11.13.5 Medpace Holdings, Inc. Recent Development

11.14 IQVIA

11.14.1 IQVIA Company Details

11.14.2 IQVIA Business Overview

11.14.3 IQVIA Biologics Regulatory Affairs Outsourcing Introduction

11.14.4 IQVIA Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

11.14.5 IQVIA Recent Development

11.15 Syneos Health

11.15.1 Syneos Health Company Details

11.15.2 Syneos Health Business Overview

11.15.3 Syneos Health Biologics Regulatory Affairs Outsourcing Introduction

11.15.4 Syneos Health Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

11.15.5 Syneos Health Recent Development

11.16 SGS SA (SGS)

11.16.1 SGS SA (SGS) Company Details

11.16.2 SGS SA (SGS) Business Overview

11.16.3 SGS SA (SGS) Biologics Regulatory Affairs Outsourcing Introduction

11.16.4 SGS SA (SGS) Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

11.16.5 SGS SA (SGS) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Lonza

Wuxi AppTec Inc.

Thermo Fisher Scientific Inc

Eurofins Scientific SE

Charles River Laboratories International, Inc.

LabCorp

PAREXEL International

Medpace Holdings, Inc

IQVIA

Syneos Health

SGS SA (SGS)

List of Tables

Table 1. Global Biologics Regulatory Affairs Outsourcing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Regulatory Consulting

Table 3. Key Players of Legal Representation

Table 4. Key Players of Regulatory Writing & Publishing

Table 5. Key Players of Product Registration

Table 6. Key Players of Regulatory Submissions

Table 7. Key Players of Regulatory Operations

Table 8. Key Players of Others

Table 9. Global Biologics Regulatory Affairs Outsourcing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Biologics Regulatory Affairs Outsourcing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Biologics Regulatory Affairs Outsourcing Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Biologics Regulatory Affairs Outsourcing Market Share by Region (2020-2025)

Table 13. Global Biologics Regulatory Affairs Outsourcing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Biologics Regulatory Affairs Outsourcing Market Share by Region (2026-2031)

Table 15. Biologics Regulatory Affairs Outsourcing Market Trends

Table 16. Biologics Regulatory Affairs Outsourcing Market Drivers

Table 17. Biologics Regulatory Affairs Outsourcing Market Challenges

Table 18. Biologics Regulatory Affairs Outsourcing Market Restraints

Table 19. Global Biologics Regulatory Affairs Outsourcing Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Biologics Regulatory Affairs Outsourcing Market Share by Players (2020-2025)

Table 21. Global Top Biologics Regulatory Affairs Outsourcing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Regulatory Affairs Outsourcing as of 2024)

Table 22. Ranking of Global Top Biologics Regulatory Affairs Outsourcing Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Biologics Regulatory Affairs Outsourcing Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Biologics Regulatory Affairs Outsourcing, Headquarters and Area Served

Table 25. Global Key Players of Biologics Regulatory Affairs Outsourcing, Product and Application

Table 26. Global Key Players of Biologics Regulatory Affairs Outsourcing, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Biologics Regulatory Affairs Outsourcing Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Type (2020-2025)

Table 30. Global Biologics Regulatory Affairs Outsourcing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Type (2026-2031)

Table 32. Global Biologics Regulatory Affairs Outsourcing Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Application (2020-2025)

Table 34. Global Biologics Regulatory Affairs Outsourcing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Application (2026-2031)

Table 36. North America Biologics Regulatory Affairs Outsourcing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Biologics Regulatory Affairs Outsourcing Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Biologics Regulatory Affairs Outsourcing Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Biologics Regulatory Affairs Outsourcing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Biologics Regulatory Affairs Outsourcing Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Biologics Regulatory Affairs Outsourcing Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Biologics Regulatory Affairs Outsourcing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Biologics Regulatory Affairs Outsourcing Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Biologics Regulatory Affairs Outsourcing Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Country (2026-2031) & (US$ Million)

Table 51. Lonza AG Company Details

Table 52. Lonza AG Business Overview

Table 53. Lonza AG Biologics Regulatory Affairs Outsourcing Product

Table 54. Lonza AG Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025) & (US$ Million)

Table 55. Lonza AG Recent Development

Table 56. Wuxi AppTec Inc. Company Details

Table 57. Wuxi AppTec Inc. Business Overview

Table 58. Wuxi AppTec Inc. Biologics Regulatory Affairs Outsourcing Product

Table 59. Wuxi AppTec Inc. Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025) & (US$ Million)

Table 60. Wuxi AppTec Inc. Recent Development

Table 61. Thermo Fisher Scientific Inc. Company Details

Table 62. Thermo Fisher Scientific Inc. Business Overview

Table 63. Thermo Fisher Scientific Inc. Biologics Regulatory Affairs Outsourcing Product

Table 64. Thermo Fisher Scientific Inc. Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025) & (US$ Million)

Table 65. Thermo Fisher Scientific Inc. Recent Development

Table 66. Eurofins Scientific SE Company Details

Table 67. Eurofins Scientific SE Business Overview

Table 68. Eurofins Scientific SE Biologics Regulatory Affairs Outsourcing Product

Table 69. Eurofins Scientific SE Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025) & (US$ Million)

Table 70. Eurofins Scientific SE Recent Development

Table 71. Freyr solutions Company Details

Table 72. Freyr solutions Business Overview

Table 73. Freyr solutions Biologics Regulatory Affairs Outsourcing Product

Table 74. Freyr solutions Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025) & (US$ Million)

Table 75. Freyr solutions Recent Development

Table 76. Catalent Inc. Company Details

Table 77. Catalent Inc. Business Overview

Table 78. Catalent Inc. Biologics Regulatory Affairs Outsourcing Product

Table 79. Catalent Inc. Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025) & (US$ Million)

Table 80. Catalent Inc. Recent Development

Table 81. Piramal Group Company Details

Table 82. Piramal Group Business Overview

Table 83. Piramal Group Biologics Regulatory Affairs Outsourcing Product

Table 84. Piramal Group Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025) & (US$ Million)

Table 85. Piramal Group Recent Development

Table 86. AGC Biologics Company Details

Table 87. AGC Biologics Business Overview

Table 88. AGC Biologics Biologics Regulatory Affairs Outsourcing Product

Table 89. AGC Biologics Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025) & (US$ Million)

Table 90. AGC Biologics Recent Development

Table 91. ICON Plc. Company Details

Table 92. ICON Plc. Business Overview

Table 93. ICON Plc. Biologics Regulatory Affairs Outsourcing Product

Table 94. ICON Plc. Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025) & (US$ Million)

Table 95. ICON Plc. Recent Development

Table 96. Charles River Laboratories International, Inc. Company Details

Table 97. Charles River Laboratories International, Inc. Business Overview

Table 98. Charles River Laboratories International, Inc. Biologics Regulatory Affairs Outsourcing Product

Table 99. Charles River Laboratories International, Inc. Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025) & (US$ Million)

Table 100. Charles River Laboratories International, Inc. Recent Development

Table 101. Labcorp Company Details

Table 102. Labcorp Business Overview

Table 103. Labcorp Biologics Regulatory Affairs Outsourcing Product

Table 104. Labcorp Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025) & (US$ Million)

Table 105. Labcorp Recent Development

Table 106. Parexel International Company Details

Table 107. Parexel International Business Overview

Table 108. Parexel International Biologics Regulatory Affairs Outsourcing Product

Table 109. Parexel International Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025) & (US$ Million)

Table 110. Parexel International Recent Development

Table 111. Medpace Holdings, Inc. Company Details

Table 112. Medpace Holdings, Inc. Business Overview

Table 113. Medpace Holdings, Inc. Biologics Regulatory Affairs Outsourcing Product

Table 114. Medpace Holdings, Inc. Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025) & (US$ Million)

Table 115. Medpace Holdings, Inc. Recent Development

Table 116. IQVIA Company Details

Table 117. IQVIA Business Overview

Table 118. IQVIA Biologics Regulatory Affairs Outsourcing Product

Table 119. IQVIA Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025) & (US$ Million)

Table 120. IQVIA Recent Development

Table 121. Syneos Health Company Details

Table 122. Syneos Health Business Overview

Table 123. Syneos Health Biologics Regulatory Affairs Outsourcing Product

Table 124. Syneos Health Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025) & (US$ Million)

Table 125. Syneos Health Recent Development

Table 126. SGS SA (SGS) Company Details

Table 127. SGS SA (SGS) Business Overview

Table 128. SGS SA (SGS) Biologics Regulatory Affairs Outsourcing Product

Table 129. SGS SA (SGS) Revenue in Biologics Regulatory Affairs Outsourcing Business (2020-2025) & (US$ Million)

Table 130. SGS SA (SGS) Recent Development

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

Table 134. Authors List of This Report

List of Figures

Figure 1. Biologics Regulatory Affairs Outsourcing Picture

Figure 2. Global Biologics Regulatory Affairs Outsourcing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Biologics Regulatory Affairs Outsourcing Market Share by Type: 2024 VS 2031

Figure 4. Regulatory Consulting Features

Figure 5. Legal Representation Features

Figure 6. Regulatory Writing & Publishing Features

Figure 7. Product Registration Features

Figure 8. Regulatory Submissions Features

Figure 9. Regulatory Operations Features

Figure 10. Others Features

Figure 11. Global Biologics Regulatory Affairs Outsourcing Market Size by Application (2020-2031) & (US$ Million)

Figure 12. Global Biologics Regulatory Affairs Outsourcing Market Share by Application: 2024 VS 2031

Figure 13. Monoclonal Antibodies (mAbs) Case Studies

Figure 14. Recombinant Proteins Case Studies

Figure 15. Vaccines Case Studies

Figure 16. Cell & Gene Therapies Case Studies

Figure 17. Biosimilars Case Studies

Figure 18. Others Case Studies

Figure 19. Biologics Regulatory Affairs Outsourcing Report Years Considered

Figure 20. Global Biologics Regulatory Affairs Outsourcing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 21. Global Biologics Regulatory Affairs Outsourcing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 22. Global Biologics Regulatory Affairs Outsourcing Market Share by Region: 2024 VS 2031

Figure 23. Global Biologics Regulatory Affairs Outsourcing Market Share by Players in 2024

Figure 24. Global Biologics Regulatory Affairs Outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 25. The Top 10 and 5 Players Market Share by Biologics Regulatory Affairs Outsourcing Revenue in 2024

Figure 26. North America Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. North America Biologics Regulatory Affairs Outsourcing Market Share by Country (2020-2031)

Figure 28. United States Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Canada Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Europe Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Europe Biologics Regulatory Affairs Outsourcing Market Share by Country (2020-2031)

Figure 32. Germany Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. France Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. U.K. Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Italy Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Russia Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Nordic Countries Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Share by Region (2020-2031)

Figure 40. China Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Japan Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. South Korea Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Southeast Asia Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. India Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Australia Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Latin America Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Latin America Biologics Regulatory Affairs Outsourcing Market Share by Country (2020-2031)

Figure 48. Mexico Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Brazil Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Share by Country (2020-2031)

Figure 52. Turkey Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. UAE Biologics Regulatory Affairs Outsourcing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Lonza AG Revenue Growth Rate in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

Figure 56. Wuxi AppTec Inc. Revenue Growth Rate in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

Figure 57. Thermo Fisher Scientific Inc. Revenue Growth Rate in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

Figure 58. Eurofins Scientific SE Revenue Growth Rate in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

Figure 59. Freyr solutions Revenue Growth Rate in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

Figure 60. Catalent Inc. Revenue Growth Rate in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

Figure 61. Piramal Group Revenue Growth Rate in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

Figure 62. AGC Biologics Revenue Growth Rate in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

Figure 63. ICON Plc. Revenue Growth Rate in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

Figure 64. Charles River Laboratories International, Inc. Revenue Growth Rate in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

Figure 65. Labcorp Revenue Growth Rate in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

Figure 66. Parexel International Revenue Growth Rate in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

Figure 67. Medpace Holdings, Inc. Revenue Growth Rate in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

Figure 68. IQVIA Revenue Growth Rate in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

Figure 69. Syneos Health Revenue Growth Rate in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

Figure 70. SGS SA (SGS) Revenue Growth Rate in Biologics Regulatory Affairs Outsourcing Business (2020-2025)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions